Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 6, 2009

Primary Completion Date

July 25, 2014

Study Completion Date

July 25, 2014

Conditions
Hepatitis AHepatitis B
Interventions
PROCEDURE

Blood sampling

Blood sampling at Year 16, 17, 18, 19 and 20 and at the time of challenge dose administration and 14 days and one month after challenge dose administration (if challenge dose needed).

BIOLOGICAL

Engerix-B

Engerix-B will be administered to subjects who are not seroprotected against hepatitis B

BIOLOGICAL

Havrix

Havrix will be administered to subjects who are seronegative for anti-HAV antibodies

Trial Locations (1)

2610

GSK Investigational Site, Wilrijk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01000324 - Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult | Biotech Hunter | Biotech Hunter